Polyimide (MP-1, MMATech, Haifa, Israel), is a high performance aerospace thermoplastic used for its lubricity, stability, inertness and radiation resistance. A wear resistant thin robust bearing is needed for total hip arthroplasty (THR). After independent laboratory testing, in 2006, the author used the material as a bearing in two Reflection (Smith and Nephew, USA) hip surgeries. The first, a revision for polyethylene wear, survives with no evidence of wear, noise, new osteolysis or complications related to the MP-1 bearing after 16 yrs. The second donated his asymptomatic MP-1 hip at 6.5yrs for post-mortem examination. There were no osteoclasts, cellular reaction bland in contrast to that of polyethylene. In 2013 a clinical study with ethical committee approval was started using a Biolox Delta (Ceramtec, Germany) head against a polyimide liner in 97 patients. MMATech sold all liners, irradiated: steam 52:45. Sixteen were re-machined in New Zealand. Acetabular shells were Delta PF (LIMA, Italy). The liner locked by taper. The cohort consisted of 46:51 M:F, and ages 43 to 85, mean 65. Ten received cemented stems. For contralateral surgery, a ceramic or polyethylene liner was used. Initial patients were lower demand, later, more active patients, mountain-biking and running. All patients have on-going follow up, including MP-1 liner revision cases. There has been no measurable wear, or osteolysis around the acetabular components using weight-bearing radiographs. Squeaking within the first 6 weeks was noted in 39 number of cases and subtle increase in palpable friction, (passive rotation at 50 degrees flexion), but then disappeared. There were 6 revisions, four of which were related to cementless Stemsys implants (Evolutis, Italy) fixed distally with proximal linear lucencies in Gruen zones 1 and 7, and 2 and 6. No shells were revised and MP-1 liners were routinely changed to ceramic or polyethylene. The liners showed no head contact at the apex, with highly polished contact areas. There were no deep or superficial infections, but one traumatic anterior dislocation at 7 years associated with 5 mm subsidence of a non-collared stem. The initial squeaking and increased friction was due to the engineering of the liner / shell composite as implanted, not allowing adequate clearance for fluid film lubrication and contributed to by shell distortion during impaction. The revised bearings were “equatorial” rather than polar, and with lack of wear or creep this never fully resolved. Where the clearance was better, function was normal. The “slow” utilization was due to my ongoing concern with clearances not being correct. The revision of 4 Stemsys stems, tribology issues may have contributed, but non “MP-1” / Stemsys combinations outside this study have shown the same response, thought to be due to de-bonding of the hydroxyapatite coating. With correct engineering and clearances, a 3.6 mm thick MP-1 bearing, a surface Ra<0.5, steam sterilized, shows no appreciable wear, and with confidence, can be used as a high performance THR bearing

Total hip arthroplasty (THA) is a common and extremely beneficial procedure that is being performed more often as the population ages. Current THA follow-up guidelines require large amounts of resources and may not justify their cost with increased patient outcomes. Most problems that would require THA revision will cause symptoms. Late-presenting asymptomatic THAs that are found to require revision are complicated and expensive to address and often lead to poor patient outcomes. Follow-up visits for THA patients are essentially a screening tool to identify asymptomatic THAs that require revision. The rate of asymptomatic THA revision and the subsequent cost of screening for them is not well reported in the literature. Given the relative shortage of orthopaedic resources, efficient use of clinic time should be a priority and inefficient practices should be identified and changed. We calculated the rate of asymptomatic hip revisions over the first twenty years of THA ownership. We further calculated the cost of a single visit to the orthopaedic clinic for follow up of a THA. Finally, we calculated the cost savings of decreasing the follow-up schedule to a total of three visits. The cost savings of foregoing the screening to identify one asymptomatic THA requiring revision is CAD $1.2 million. Asymptomatic THAs requiring revision are rare and, as such, require a large amount of follow up to diagnose. As a screening tool, regular orthopaedic follow up of THA is an inefficient use of resources. Current follow-up guidelines are cost-prohibitive and should be made much less frequent in order to save resources

Introduction:. The addition of neck-stem modularity of femoral components allowed for increased versatility in controlling stability, head center, and limb length in total hip arthroplasty (THA). Recent reports of neck-stem corrosion, complicated by adverse local tissue reaction, have raised concern and prompted further patient evaluation for revision arthroplasty. Methods:. This was a single center, retrospective case series of thirteen hips in twelve patients. The cohort included eight women and four men, with an average age of 69.5 years (range 50–82), who underwent primary THA with a dual-taper femoral component with a titanium alloy stem, cobalt-chromium (CoCr) alloy modular neck and CoCr alloy head. Patients were followed an average of 34.3 months postsurgical (range 24–38.5 months). Each patient underwent serologic studies including metal ion levels, and Metal Artifact Reduction Sequence (MARS) magnetic resonance imaging (MRI) or Ultrasound. All patients were then referred for fluoro-assisted hip aspiration. Four patients underwent revision surgery. Results:. Ten of thirteen hips were symptomatic at the time of evaluation. ESR and CRP were normal in all patients. Serum Cobalt was elevated in 10/12 patients, with an average serum Cobalt level 4.16 mcg/L (range 1.7–9.4). Serum Chromium levels were normal in all patients. MRI was completed in eleven of twelve patients, with abnormal findings consistent with adverse local tissue reaction in nine hips. Three hips were normal by MRI. One patient had an abnormal ultrasound. Hip aspirations were positive in nine hips, negative in three, and indeterminate in one. Asymptomatic hips (3/13) all had elevated cobalt levels, and 2/3 had positive MRI and aspirates. One patient had a normal MRI and a negative aspirate. Of ten symptomatic hips, eight had elevated cobalt. 7/10 had an abnormal MRI, 2/10 a normal MRI, and 1 abnormal Ultrasound. 5/10 had aspirates that were consistent with the MRI. One aspirate was indeterminate. Four symptomatic patients had discrepancies between MRI findings and aspiration (negative MRI with positive aspirate, or vice versa); one patient had normal labs and MRI, but a positive aspirate, and was noted to have extensive adverse local tissue reaction at revision. Discussion:. Patients with dual-taper femoral stems are at risk of neck-stem corrosion and adverse local tissue reactions. The workup of these patients should include serologic studies as well as advanced imaging with MRI or Ultrasound. Hip aspiration may be a useful adjunct in identifying underlying soft tissue destruction in patients with normal or indeterminate labs or advanced imaging

Introduction. Acetabular dysplasia cause hip joint osteoarthritis(OA) by change hip mechanism. However, to our best knowledge, no studies have been published using prospectively collected data from asymptomatic young age volunteers, precise radiographic method. The purpose of this study is to evaluate the prevalence of hip dysplasia in asymptomatic Korean population as one of the most important risk factor of hip OA. Materials & Methods. From December 2014 to March 2015, we investigated prospectively collected retrospectively reviewed data of 200 asymptomatic volunteers 400 hips in age between 18 and 50 years recruited from our institution. Pelvic radiographs were taken and all radiographs were reviewed by 2 experienced orthopedic surgeons. Lateral center-edge angle(LCEA), Sharp angle, Tonnis angle and acetabular width-depth ratio were measured. We analyzed the statistical differences of these values between sex by Mann-Whitney U test and independent t-test. Pearson's correlation coefficient was used to measure the relationship between dysplasia parameters. Results. On the Pelvic AP view, 60 of the 400 hips (15%) were dysplastic hip as LCEA <20°. In 146 male hips, 17 hips (11.6%) were LCEA <20°. In 254 female hips, 43 hips(16.9%) were LCEA <20°. There was no strong correlation of LCEA with other measurements. Conclusion. There are large number of asymptomatic dysplastic hips in Asian population compared previously investigated

The mean age of patients with osteonecrosis reported in series in our literature is 38 to 53. Thus, performing a total hip replacement on a patient who would need a procedure to last 40–45 years is a concern. Patients with osteonecrosis of the hip require some type of surgical treatment. Without treatment, a large majority of femoral heads in patients even with Ficat stage I osteonecrosis will collapse or become symptomatic. A common scenario is a patient who first presents to the orthopaedic surgeon with severe arthritis secondary to osteonecrosis in one hip and a normal appearing radiograph on the asymptomatic contralateral side. Performing a total hip on the severe arthritic hip is usually not debated. A MRI will commonly show Ficat stage I osteonecrosis on the asymptomatic contralateral hip. Some method of core decompression is a reasonable choice if it is non-steroid induced, small more medially positioned lesion, but not for other Ficat stage 1 lesions or those with more advanced stages. The problem is convincing the patient to have anything done when they are asymptomatic. Because results with total hip replacement for patients with osteonecrosis of the hip have significantly improved, most patients with a symptomatic hip prefer arthroplasty as treatment. Arthroplasty has become the predominant surgical treatment for osteonecrosis of the hip in the United States. 88% of procedures performed on 6,400 patients with osteonecrosis in 2008 reported in the Nationwide Inpatient Sample Database of the hip were total hip replacements. From 16 years earlier, the number of procedures performed had almost doubled and the percentage use of arthroplasty as the performed treatment had increased by 13%. I expect both numbers will continue to increase

The mean age of patients with osteonecrosis reported in series in our literature is 38 to 53. Thus, performing a total hip replacement on a patient who would need a procedure to last 40–45 years is a concern. Patients with osteonecrosis of the hip require some type of surgical treatment. Without treatment, a large majority of femoral heads in patients even with Ficat stage I osteonecrosis will collapse or become symptomatic. A common scenario is a patient who first presents to the orthopaedic surgeon with severe arthritis secondary to osteonecrosis in one hip and a normal appearing radiograph on the asymptomatic contralateral side. Performing a total hip on the severe arthritic hip is usually not debated. A MRI will commonly show Ficat stage I osteonecrosis on the asymptomatic contralateral hip. Some method of core decompression is a reasonable choice if it is non-steroid induced, small more medially positioned lesion, but not for other Ficat stage 1 lesions or those with more advanced stages. The problem is convincing the patient to have anything done when they are asymptomatic. Because results with total hip replacement for patients with osteonecrosis of the hip have significantly improved, most patients with a symptomatic hip prefer arthroplasty as treatment. Arthroplasty has become the predominant surgical treatment for osteonecrosis of the hip in the United States. Eighty-eight percent of procedures performed on 6,400 patients with osteonecrosis in 2008 reported in the Nationwide Inpatient Sample Database of the hip were total hip replacements. From 16 years earlier, the number of procedures performed had almost doubled and the percentage use of arthroplasty as the performed treatment had increased by 13%. I expect both numbers will continue to increase